318 results on '"Ballas, Samir K"'
Search Results
2. Review/overview of pain in sickle cell disease
3. Opioids are not a major cause of death of patients with sickle cell disease
4. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome
5. Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes
6. The role of blood rheology in sickle cell disease
7. Plasmapheresis may improve clinical condition in sickle cell disease through its effects on red blood cell rheology
8. Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease
9. Sickle cell pain: a critical reappraisal
10. The Impact of Hydroxyurea on Career and Employment of Patients With Sickle Cell Anemia
11. Hydroxyurea and Acute Painful Crises in Sickle Cell Anemia: Effects on Hospital Length of Stay and Opioid Utilization During Hospitalization, Outpatient Acute Care Contacts, and at Home
12. Safety and efficacy of blood exchange transfusion for priapism complicating sickle cell disease
13. Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study
14. Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease
15. Deep venous thrombosis in children with sickle cell disease
16. Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea
17. Stabilization of Erythrocyte Membranes by Polyamines
18. Costs to hospitals of acquiring and processing blood in the US: A survey of hospital-based blood banks and transfusion services
19. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
20. Thinking beyond sickling to better understand pain in sickle cell disease
21. Practice Guideline for Pulmonary Hypertension in Sickle Cell: Direct Evidence Needed before Universal Adoption
22. Treatment of the acute sickle cell vaso-occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine
23. Haemolysis and abnormal haemorheology in sickle cell anaemia
24. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia
25. Newborn Screening Program for Hemoglobinopathies in Rio De Janeiro, Brazil
26. Neuropathy, neuropathic pain, and sickle cell disease
27. The first Cardeza donor center: attracting donors who do not wish to see blood
28. More definitions in sickle cell disease: Steady state v base line data
29. Mild haemorheological changes induced by a moderate endurance exercise in patients with sickle cell anaemia
30. The Association Between Hydroxyurea Treatment and Pain Intensity, Analgesic Use, and Utilization in Ambulatory Sickle Cell Anemia Patients
31. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapoc (ICA-17043)
32. Leg ulcers in sickle cell disease
33. Not All Strokes in Sickle Cell Anemia Are Due to Sickle Vasculopathy: 093
34. Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: Effect of sex, age, and geographical location
35. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
36. Definitions of the phenotypic manifestations of sickle cell disease
37. The cost of health care for patients with sickle cell disease
38. Pain Management of Sickle Cell Disease
39. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions
40. Morbidity and Mortality in Chronically Transfused Subjects With Thalassemia and Sickle Cell Disease: A Report From the Multi-Center Study of Iron Overload
41. Bloodstream Infections in Hospitalized Adults with Sickle Cell Disease: A Retrospective Analysis
42. N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
43. Folate Supplementation and Twinning in Patients With Sickle Cell Disease
44. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia
45. Blood Samples Collected Under Venous Oxygen Pressure From Patients With Sickle Cell Disease Contain a Significant Number of a New Type of Reversibly Sickled Cells: Constancy of the Percentage of Sickled Cells in Individual Patients During Steady State
46. Aggregation of Normal and Sickle Hemoglobin in High Concentration Phosphate Buffer
47. Hemoglobin I Mutation Encoded at Both α-globin Loci on the Same Chromosome: Concerted Evolution in the Human Genome
48. Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia – lessons learned for prophylaxis.
49. Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment
50. L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.